Medicine, Health & Food
Volume: 92 , Issue: 1 , January Published Date: 13 January 2022
Publisher Name: IJRP
Views: 467 , Download: 424 , Pages: 547 - 562
DOI: 10.47119/IJRP100921120222751
Publisher Name: IJRP
Views: 467 , Download: 424 , Pages: 547 - 562
DOI: 10.47119/IJRP100921120222751
Authors
# | Author Name |
---|---|
1 | Khoirunnisa Novitasari |
2 | Brahmana Askandar Tjokroprawiro |
Abstract
Ovarian cancer is often asymptomatic, grows rapidly and most diagnosed at advanced stage. Till now there is no method for early detection. Its incidence and mortality rate are increasing. Actually, non-epithelial type of ovarian cancer most found in young women and has better prognosis with adequate therapy. The main therapy for non-epithelial ovarian cancer is surgery, both radical and conservative (fertility sparing). Postoperative chemotherapy depends on the type and stage, although platinum-based chemotherapy regimens are used in almost all cases because of their chemosensitivity. The first-line regimens used are bleomycin, etoposide and cisplatin. Some clinical characteristics could affect prognosis including recurrence and survival rate. They include patient?s age, cancer stage, tumor size, tumor marker, post-operative tumor residue, histopathological type of cancer, and chemotherapy. Better knowledge of those prognostic factor will lead to better management of patients with non-epithelial ovarian cancer and increase survival rate.